Andrea F. Wainer - Dec 23, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Dec 23, 2021
Transactions value $
-$1,581,500
Form type
4
Date filed
12/28/2021, 04:41 PM
Previous filing
Dec 21, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $141K +3K +6.03% $47.00 52.8K Dec 23, 2021 Direct
transaction ABT Common shares without par value Options Exercise $384K +10K +18.95% $38.40 62.8K Dec 23, 2021 Direct
transaction ABT Common shares without par value Sale -$1.82M -13K -20.71% $140.00 49.8K Dec 23, 2021 Direct
transaction ABT Common shares without par value Options Exercise $141K +3K +6.03% $47.00 52.8K Dec 27, 2021 Direct
transaction ABT Common shares without par value Sale -$428K -3K -5.68% $142.50 49.8K Dec 27, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -3K -21.09% $0.00 11.2K Dec 23, 2021 Common Shares 3K $47.00 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -10K -66.67% $0.00 5K Dec 23, 2021 Common Shares 10K $38.40 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -3K -26.72% $0.00 8.23K Dec 27, 2021 Common Shares 3K $47.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).